Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Solid Biosciences Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 92
- −12 vs. Q1 2021
- Shares held
- 80.2M
- +1.06M (+1.3%) vs. Q1 2021
- Total value
- $293.4M
- −$144.2M (−33.0%) vs. Q1 2021
- New holders
- 13
- 37 more added
- Sold out
- 25
- 23 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLDB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $1.14B |
| Q1 2026 | 150 | $717.4M |
| Q4 2025 | 132 | $459.2M |
| Q3 2025 | 129 | $505.2M |
| Q2 2025 | 116 | $403.4M |
| Q1 2025 | 125 | $293.2M |
| Q4 2024 | 90 | $145.3M |
| Q3 2024 | 92 | $249.8M |
| Q2 2024 | 80 | $213.2M |
| Q1 2024 | 56 | $465.9M |
| Q4 2023 | 40 | $102.2M |
| Q3 2023 | 37 | $40.7M |
| Q2 2023 | 36 | $85.6M |
| Q1 2023 | 39 | $74.8M |
| Q4 2022 | 35 | $85.6M |
| Q3 2022 | 58 | $33.4M |
| Q2 2022 | 67 | $39.5M |
| Q1 2022 | 78 | $83.3M |
| Q4 2021 | 82 | $132.2M |
| Q3 2021 | 91 | $184.3M |
| Q2 2021 | 92 | $293.4M |
| Q1 2021 | 104 | $437.6M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Solid Biosciences Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −29,500−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −25,700−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −24,796−100.0% | Sold out |
| New York Life Investments Alternatives | 0 | $0 | 0.00% | −24,746−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −20,776−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −17,575−100.0% | Sold out |
| Sculptor Capital LP | 0 | $0 | 0.00% | −15,100−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −13,834−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −12,889−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −12,964−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −12,600−100.0% | Sold out |
| Athanor Capital, LP | 0 | $0 | 0.00% | −12,192−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −5,607−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −4,316−100.0% | Sold out |
| Close Asset Management Ltd | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −737−100.0% | Sold out |